In patients with sleep-disordered breathing (SDB), Domagała-Kulawik et al. found that the median serum adiponectin levels were significantly reduced in OSA patients compared with healthy subjects (p < 0.05). Here, ADIPOQ is linked to sleep apnea syndrome.